Evidence map›Paper›PMID 38882544›Full record

ReviewInternational journal of nanomedicine2024

Biomimetic ZIF-8 Nanoparticles: A Novel Approach for Biomimetic Drug Delivery Systems.

Yao Wang, Mingtang Zeng, Tianfei Fan, Ming Jia, Ruxi Yin, Jia Xue, Longjun Xian, Ping Fan, Mei Zhan

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. ZIF-8 nanoplatform coordinating ZnInternational journal of pharmaceutics: X · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yao Wang *Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Mingtang Zeng *Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Tianfei FanDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Ming JiaNanchong Institute for Food and Drug Control, Nanchong, People's Republic of China.
Ruxi YinDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Jia XueDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Longjun XianDepartment of Thoracic Surgery, Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Ping FanDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Mei ZhanDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal-organic frameworks (MOFs) are porous materials resulting from the coordination of metal clusters or ions with organic ligands, merging macromolecular and coordination chemistry features. Among these, zeolitic imidazolate framework-8 (ZIF-8) stands out as a widely utilized MOF known for its robust stability in aqueous environments owing to the robust interaction between its constituent zinc ions (Zn

Indexed as

Biomimetic MaterialsDrug Delivery SystemsImidazolesMetal-Organic FrameworksNanoparticlesZeolitesAnimalsBiomimeticsDrug CarriersHumansHydrogen-Ion ConcentrationZinc2-methylimidazoleDrug CarriersImidazolesMetal-Organic FrameworksZeolitesZIF-8 metal-organic frameworkZincbiomimetic drug deliverycell membraneMOFZIF-8

Identifiers

PMID38882544
PMCPMC11178078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.